Statistics

Total Visits

Views
Successful discontinuation of eltrombopag after complete remission in patients with primary immune thrombocytopenia51

Select a period of time:

Number of views in the range

Views
Successful discontinuation of eltrombopag after complete remission in patients with primary immune thrombocytopenia26

Views

Views
December 20251
January 20264
February 20263
March 202612
April 20262
May 20262
June 20262
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States17
Argentina1
Brazil1
Chile1
Algeria1
Finland1
Netherlands1
Turkey1
Trinidad and Tobago1
Uruguay1
 

Top cities views

Views
San Jose10
Beni Saf1
Chaguanas1
Duque de Caxias1
Groningen1
Helsinki1
Montevideo1
Newark1
San Miguel de Tucumán1
Santiago1